Results 201 to 210 of about 8,112 (240)
Some of the next articles are maybe not open access.
Hereditary angioedema and pregnancy
The Journal of Maternal-Fetal & Neonatal Medicine, 2007Hereditary Angioedema is a rare but potentially life threatening condition. It is important that Obstetricians are aware of this condition as it affects women in the reproductive years and thus its recognition and proper management in pregnancy is crucial.
S, Duvvur, F, Khan, K, Powell
openaire +2 more sources
An update on hereditary angioedema
Current Opinion in Pediatrics, 2012To review and update the management and understanding of hereditary angioedema (HAE), while integrating insights into pediatric subtleties that exist in practice.Major advances have recently been made in HAE treatment. Ecallantide (a kallikrein inhibitor approved for use in the United States in December 2009) and icatibant (a selective bradykinin B2 ...
Derek, Hsu, Marcus, Shaker
openaire +2 more sources
Management of hereditary angioedema
Nursing Standard, 2013Hereditary angioedema is characterised by unpredictable, painful and potentially life-threatening oedema. Recently, some C1 inhibitors have been approved for self-administration and/or routine prevention, enabling patients to be proactive in managing their disease and reducing the burden of illness.
openaire +2 more sources
The management of hereditary angioedema
La Ricerca in Clinica e in Laboratorio, 1983Our experience in managing 120 cases of hereditary angioedema is reported. Forty-two severe episodes of mucous or subcutaneous edema were successfully managed using CI-INH concentrate. A prophylactic treatment was done with two classes of drugs: antifibrinolytic agents (tranexamic acid) and 17α-alkylated androgen derivatives.
openaire +2 more sources
Hereditary and acquired angioedema
Allergy and Asthma Proceedings, 2019Hereditary angioedema (HAE) is an autosomal dominant disorder defined by a deficiency of functional C1 esterase inhibitor (C1-INH). Acquired angioedema is due to either consumption (type 1) or inactivation (type 2) of CI-INH. Both HAE and acquired angioedema can be life-threatening.
Gayatri, Patel, Jacqueline A, Pongracic
openaire +2 more sources
Icatibant for hereditary angioedema
Drugs of Today, 2009Hereditary angioedema (HAE) is an autosomal dominant, potentially life-threatening disease, characterized by recurrent self-limiting bouts of edema mainly involving the extremities, genitalia, face, intestines and airways. The prevalence of HAE in the general population has been estimated to be in the range of 1:10,000 to 1:150,000.
openaire +2 more sources
Treatment of Hereditary Angioedema
JAMA: The Journal of the American Medical Association, 1979To the Editor.— In his letter "Hereditary Angioedema" (240:2155, 1978), Dr Reimann does not mention the use of androgenic steroids for prophylaxis of attacks. Methyltestosterone was first effectively used by Spaulding 1 in 1960. This was followed by reports of effectiveness of less virilizing analogues, fluoxymesterone, oxymetholone, 2 and danazol.
openaire +2 more sources
The pathogenesis of hereditary angioedema
Transfusion and Apheresis Science, 2003Hereditary angioedema (HAE), which is characterized by episodic localized angioedema of the skin or mucosa, results from heterozygous deficiency of the plasma protease inhibitor, C1 inhibitor (C1INH). The most obvious biologic role of C1INH, therefore, is prevention of excessive vascular permeability.
openaire +2 more sources